H77S.3/Blast5A and H77S/Blast5A/AAG, respectively, were transfected into 
64
We also performed a similar study using Huh-7.5 cells harboring Fig. S9 ).
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We performed clonal sequence analysis to investigate the HCV sequences 
247
At the same time, simeprevir, daclatasvir, or sofosbuvir was added in a serial 248 dilution. We replaced the medium with fresh medium containing DAA 48 h later.
249
After 24 h, the supernatant was harvested, and GLuc activity was determined.
250
The EC 50 of simeprevir (d), daclatasvir (e), and sofosbuvir (f) in the presence of Time after LNA-anti-miR-122 (LNA-RNA-Control) transfection Relative replication capacity normalize to non treatment group(%) (With non treatment set to 100%)
